Abstract
Focused Clinical Question: Debates and questions related to the newly developed two-vector system
for classification of periodontal diseases have emerged as to how to accurately assign stage and grade
to the periodontitis cases. The aim of the present manuscript is to demonstrate the essential thought
processes that are needed in utilizing the new periodontitis classification system to diagnose two gray
zone cases.
Summary: Clinical case 1 includes an 83-year old patient diagnosed with periodontitis and classified as
Generalized Stage III Grade B periodontitis, while clinical case 2 , a 73-year old male was classified as
presenting Generalized Stage IV Grade B periodontitis. Although clinical and radiographic evaluations
revealed similarities between the cases, the thought process that includes clinical judgement is
described to guide a more accurate diagnosis following the guidelines of the new classification
system.
Conclusion: The two cases demonstrated here offer an opportunity for clinicians to recognize the
essential role of sound clinical judgment in certain cases when applying the new periodontal disease
classification system and also to clarify questions emerging from implementing this classification
system.
Key words: Staging and grading of periodontal diagnosis, Periodontal Diseases, Periodontal Diagnosis,
Periodontitis is a chronic, slowly progressing disease which mainly results in the destruction of tooth supporting apparatus. Earlier it was classified as Chronic and Aggressive periodontitis with different clinical features and etiology. Current classification ( 2017) of periodontal disease involves periodontitis with is further divided into 4 stages and 3 grades depending on severity and rate of disease progression respectively. Diabetes meelitus and smoking are the validated risk factors for the progression of periodontitis.
Chronic periodontitis is an infectious disease resulting in inflammation within the supporting tissues of the teeth, progressive attachment loss, and bone loss. It is no more a separate entity, as earlier it had Aggressive periodontitis as a differential diagnosis. According to the New Classification from the 2017 World Workshop on Periodontal and Peri- Implant Disease and Conditions, it is now classified further into stages and grades under Periodontitis.
Periodontitis is a chronic, slowly progressing disease which mainly results in the destruction of tooth supporting apparatus. Earlier it was classified as Chronic and Aggressive periodontitis with different clinical features and etiology. Current classification ( 2017) of periodontal disease involves periodontitis with is further divided into 4 stages and 3 grades depending on severity and rate of disease progression respectively. Diabetes meelitus and smoking are the validated risk factors for the progression of periodontitis.
Chronic periodontitis is an infectious disease resulting in inflammation within the supporting tissues of the teeth, progressive attachment loss, and bone loss. It is no more a separate entity, as earlier it had Aggressive periodontitis as a differential diagnosis. According to the New Classification from the 2017 World Workshop on Periodontal and Peri- Implant Disease and Conditions, it is now classified further into stages and grades under Periodontitis.
68.Dr. Afreen Kauser; Dr. Rahul VC Tiwari; Dr. Ankita Khandelwal; Dr. Heena Tiwari; Dr. Sourabh Ramesh Joshi; Dr. Fawaz Abdul Hamid Baig; Dr. Anil Managutti. "Preference Of Orthodontic Treatment Versus Orthognathic Surgery In Class Iii Malocclusion Cases: A Research Survey". European Journal of Molecular & Clinical Medicine, 8, 1, 2021, 1271-1276.
CONSCIOUS SEDATION USE ON ANXIETY REDUCTION, AND PATIENT AND SURGEON SATISF...Dr. B.V.Parvathy
EFFECT OF CONSCIOUS
SEDATION USE ON ANXIETY REDUCTION, AND PATIENT
AND SURGEON
SATISFACTION IN DENTAL
IMPLANT SURGERIES: A
SYSTEMATIC REVIEW AND META-ANALYSIS
Orthodontics-Periodontics Relationship
ntroduction
Biological basis for orthodontic therapy
Periodontal tissue response to orthodontic force
Effects of orthodontic tooth movement on the periodontium
Orthodontic tooth movement in adults with periodontal tissue breakdown
Specific factors associated with orthodontic tooth movement
Implants and orthodontic therapy
Systematics of combined ortho – perio treatment
Periodontally Accelerated Osteogenic Orthodontics (PAOO)
Minor periodontal surgery and orthodontic treatment
Review of literature
68.Dr. Afreen Kauser; Dr. Rahul VC Tiwari; Dr. Ankita Khandelwal; Dr. Heena Tiwari; Dr. Sourabh Ramesh Joshi; Dr. Fawaz Abdul Hamid Baig; Dr. Anil Managutti. "Preference Of Orthodontic Treatment Versus Orthognathic Surgery In Class Iii Malocclusion Cases: A Research Survey". European Journal of Molecular & Clinical Medicine, 8, 1, 2021, 1271-1276.
CONSCIOUS SEDATION USE ON ANXIETY REDUCTION, AND PATIENT AND SURGEON SATISF...Dr. B.V.Parvathy
EFFECT OF CONSCIOUS
SEDATION USE ON ANXIETY REDUCTION, AND PATIENT
AND SURGEON
SATISFACTION IN DENTAL
IMPLANT SURGERIES: A
SYSTEMATIC REVIEW AND META-ANALYSIS
Orthodontics-Periodontics Relationship
ntroduction
Biological basis for orthodontic therapy
Periodontal tissue response to orthodontic force
Effects of orthodontic tooth movement on the periodontium
Orthodontic tooth movement in adults with periodontal tissue breakdown
Specific factors associated with orthodontic tooth movement
Implants and orthodontic therapy
Systematics of combined ortho – perio treatment
Periodontally Accelerated Osteogenic Orthodontics (PAOO)
Minor periodontal surgery and orthodontic treatment
Review of literature
To evaluate the effects of B. lactis HN019 on clinical periodontal parameters (plaque accumulation and gingival bleeding), on the immunocompetence of gingival tissues [expression of BD-3, Toll-like receptor 4 (TLR4), cluster of differentiation (CD)-57 and CD-4], and on immunological properties of saliva (IgA levels) and adhesion to buccal epithelial cells and antimicrobial properties in non-surgical periodontal therapy in GCP patients.
INTRODUCTION
KEY ELEMENTS IN TISSUE ENGINEERING
- Progenitor cells
- Scaffold
- Signalling molecules
DESIRED PROPERTIES AND WAYS TO ENHANCE THE REGENERATIVE CAPACITY OF SCAFFOLDS
4. GENE THERAPY IN PERIODONTAL TISSUE ENGINEERING
5. RECENT DEVELOPMENTS
6. CRITICAL ANALYSIS OF PRESENT STATUS OF TISSUE ENGINEERING FOR PERIODONTICS.
4. CONCLUSION
5. REFERENCES
To evaluate the efficacy of the GPCS for palatal hemostasis during and after the FGG harvesting procedure.
A secondary objective was to evaluate if the placement of the suture improved the operator
visibility thereby reducing the surgical time.
Comparative study of DFDBA and FDBA block grafts.pptxDr. B.V.Parvathy
To evaluate and compare the effectiveness of demineralized freeze dried block graft and freeze dried block graft with chorion membrane as barrier membrane clinically and radiographically for the treatment of residual deep intra bony defects.
Abstract
Aim: The aim of this study was to determine whether the combined connective tissue
graft (CTG) with injectable platelet‐rich fibrin (i‐PRF) with coronally advanced flap
(CAF) improved root coverage of deep Miller Class I or II gingival recessions com‐
pared with CTG alone with CAF.
Material and Methods: Seventy‐two patients with Miller class I and II gingival reces‐
sions were enrolled. Thirty‐six patients were randomly assigned to the test group
(CAF+CTG+i‐PRF [700 rpm for 3 min]) or control group (CAF+CTG). Clinical evalua‐
tions were made at 6 months.
Results:At 6months, complete root coveragewas obtained at 88% of the sites treated
with CAF+CTG+i‐PRF and 80% of the sites treated with CAF+CTG. Difference be‐
tween the two groups was not statistically significant. At 6 months, the recession
depth (RD) reduction and increase in keratinized tissue height (KTH) of the test sites
were significantly better compared with the control sites.
Conclusions: According to the results, the addition of i‐PRF to the CAF+CTG treat‐
ment showed further development in terms of increasing the KTH and decreasing
RD. However, this single trial is not sufficient to advocate the true clinical effect of
i‐PRF on recession treatment with CAF+CTG and additional trials are needed.
KEYWORDS
connective tissue graft, injectable platelet‐rich fibrin, root coverage
DEFINITION
ETIOLOGY
HISTORICAL PRESPECTIVE
TERMINOLOGIES WHICH HAVE BEEN USED TO DESCRIBE OCCLSAL TRAUMA
REVIEW OF LITERATURE
OCCLUSAL FORCES DURING JAW MOVEMENTS
CLASSIFICATION
STAGES OF TISSUE RESPONSE TO EXCESSIVE OCCLUSAL FORCES
EXAMINATION AND DIAGNOSIS
DEFINITION
INDICATION AND OBJECTIVES
PROCEDURES FOR INCREASING WIDTH OF ATTACHED GINGIVA
PROCEDURES FOR ROOT COVERAGE
TECHNIQUES FOR CORRECTION OF ABERRANT FRENUM
PAPILLA RECONSTRUCTION
RIDGE AUGMENTATION
PROCEDURES FOR INCREASING VESTIBULAR DEPTH
CROWN LENGTHENING PROCEDURES
The Efficacy of Pocket Elimination/Reduction Compared to Access Flap Surgery: A SystematicReview and Meta-analysis
To assess the efficacy and adverse effects of resective
surgery compared to access flap in patients with
periodontitis.
Impact of Different Surgical Protocols on Dimensional Changes of Free Soft Ti...Dr. B.V.Parvathy
To determine if there is a difference in the amount of shrinkage during
healing of free soft tissue autografts (FSTA) using different surgical
techniques—suturing the vestibular flap margin apically to the base of
the recipient bed versus leaving the flap margin free and unsutured.
Regenerative Surgical Treatment of Furcation Journal PresentationDr. B.V.Parvathy
AIM
To evaluate the performance and the added values of surgical regenerative techniques in terms of tooth loss, furcation closure/conversion, horizontal bone level gain and other periodontal parameters of teeth affected by periodontitis-related furcation defects, at least 12 months after surgery.
i-prf &MN in gingival augmentation in thin phenotypeDr. B.V.Parvathy
To evaluate the effect of gingival thickness (GT) and keratinized tissue width (KTW) using injectable platelet rich fibrin (i-PRF) alone and with microneedling (MN) in individuals with thin periodontal phenotypes.
Local Treatment in Periodontal pocket Journal PresentationDr. B.V.Parvathy
It was a systematic review and network meta-analysis aimed to evaluate the efficacy of adjunctive locally delivered antimicrobials, compared to sub gingival instrumentation alone or plus a placebo, on changes in probing pocket depth (PPD) and clinical attachment level (CAL), in patients with residual pockets during supportive periodontal care.
2 Stage Crown Lengthening VS 1 Stage Journal PresentationDr. B.V.Parvathy
This randomized controlled trial aimed to assess the efficacy of a two-
stage crown lengthening intervention (SCL) in the aesthetic zone
compared with a one-stage crown lengthening procedure (CCL).
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
2. Rafael Siqueira, Nathalia Andrade, Shan-Huey Yu, Kenneth S . Kornman, Hom-Lay Wang
Challenges And Decision making For The Classification Of
Two Complex Periodontal Cases
2020 Nov 4
4. HOWTO DECIDE
• Periodontitis ???
Ideally done by assessing presence of clinical attachment loss but, if
(i) interproximal attachment loss is present at least at two different, non-adjacent
teeth, and (ii) the observed attachment loss cannot be attributed to traumatic factors
or non-periodontitis related etiologies (e.g., root fracture, endodontic infection,
surgical trauma).
In the absence of interproximal attachment loss, but if attachment loss that
cannot be ascribed to non-periodontitis-related causes is present at buccal or
lingual surfaces, diagnosis of periodontitis requires presence of clinical
attachment loss of ≥ 3mm and probing depth of ≥ 3 mm at ≥ 2 teeth.
5. Clinicians will confirm the presence of attachment loss by corresponding
interproximal alveolar bone loss on radiographs.
Tissue loss needs to encompass a substantial portion of the buccal-lingual
dimension before it can be visualized by conventional radiographs. Thus, absence
of readily discernible bone loss does not preclude presence of frank periodontitis
of incipient severity.
• Stage assessment ???
Stage I and II patients show periodontitis of incipient or moderate
severity, have not lost any teeth due to the disease, and respond predictably to
standard therapy based on the principles of sustainable reduction of the
bacterial burden.
6. In stage III and stage IV periodontitis patients, it is most likely that one or
several intrinsic or environmental risk factors adversely affect the ability of
the host to respond to the bacterial infection and to contain the tissue
damage.
Requires high-level assessment of the patient’s medical history,
radiographs, and probing chart to distinguish between Stage I or II vs
Stage III or IV periodontitis, using two key discriminatory variables that can
distinguish between the two aggregate groups, i.e., the severity of tissue
damage and the presence of periodontitis-associated tooth loss.
8. Selected periapical radiographs that capture one patient’s overall general radiographic
bone loss, which is in the coronal third of the root length. The orange box in the Figure
defines characteristics of Stages I and II, which include the most likely severity of
periodontitis. For this patient. This initial high-level disease assessment guides clinicians to
target Stages I and II based on clinical and radiographic bone loss of patients.
9. Selected periapical radiographs that capture one patient’s overall general radiographic
bone loss, which is in the middle third or beyond of the root length. The orange box in
the Figure defines characteristics of Stages III and IV, which include the most likely
severity of periodontitis for this patient. This initial high-level disease assessment guides
clinicians to target the parameters listed for Stages III and IV based on clinical and
radiographic bone loss of patients.
10. In this step, the clinician needs to study in detail the available full-mouth
periodontal charting and full-mouth series of intra-oral radiographs. The
distinction between Stage I & II periodontitis will be primarily carried out by
evaluating severity of bone loss at areas of the dentition with the most advanced
destruction.
• How to reliably differentiate between bone loss of up to 15% of the root
length vs bone loss extending between 15% and 33% of the root length???
Clear interproximal bone loss within the coronal third of the root length,
means Stage II rather Stage I disease.
Stage I disease is usually characterized by incipient attachment loss in the
presence of early radiographic evidence of disruption in the alveolar bone
support example, a break in the integrity of the lamina dura rather than
pronounced increase in the CEJ-bone crest distance.
11. If the preliminary assessment is that the patient suffers from either Stage III or
Stage IV periodontitis, the distinction between these two stages will be based either on
the amount of tooth loss that can be attributed to periodontitis (1-4 teeth versus 5 or
more teeth lost) or on the presence of the various complexity factors.
The following two central questions that essentially
represent a distillation of the case’s treatment:
(i) does the patient’s extent and severity of
periodontitis constitute a threat for the survival of
individual teeth or rather of the survival of the entire
dentition?
(ii) does the total therapy envisioned to address the sequalae of periodontitis in the
particular patient involve extensive, multi-disciplinary oral rehabilitation?
12. The terms “localized” or “generalized” will be used to describe the extent of the
dentition that is affected by the Stage-defining severity.
E.g., localized Stage III periodontitis, include segments of the dentition with mild or
moderate severity of attachment/bone loss. Acknowledged in the “narrative” portion of the
case description.
• Whether a patient’s Stage can change over time???
If a patient that has been staged at a given time point experiences significant disease
progression or disease recurrence after therapy that results in increased severity and/
or more complex treatment needs, then stage must be shifted upwards at the time of
the subsequent examination, as appropriate.
The severity of attachment loss and /or bone loss can be reduced substantially
from beyond the coronal third to within the coronal third in cases of successful
regeneration therapy, it is advised that the patient retains the Stage originally assigned
prior to the treatment.
13. • Assessment of Grade???
The primary goal of grading is to determine which of two disease paths a
specific patient is traveling on, and use this information to guide the most
appropriate treatment strategy that will lead to successful outcomes.
A “Path 1” patient has minimal likelihood of disease progression, and clinical
treatment responses are expected to be predictable after applying standard principles
of periodontitis treatment based on biofilm disruption and regular plaque control;
in contrast, in a “Path 2”patient, there is an increased likelihood of disease
progression and less predictable clinical response to standard periodontitis prevention
and treatment principles
Done based on three fundamental principles: 1) Not all individuals are equally
susceptible to periodontitis;
2) Periodontitis progression and severity is a function of multifactorial influences on
a patient’s response to the microbial challenge. Multiple factors often interact to
influence clinical phenotypes and
3) Some periodontitis cases require more intensive control of the microbial biofilm
and inflammation than achieved using current principles of care.
14. There are 3 primary goals for Grading a patient with periodontitis:
– To assist in stratifying each patient in terms of which of two general paths best
capture the patient’s periodontitis trajectory.
– To assist new protocol development for management of periodontitis cases that
are less likely to respond to current principles for periodontitis prevention and
treatment.
– To assist in development of additional approaches to management of certain
periodontitis cases that may favorably influence systemic health.
Factors to be assessed to determine the patient’s grade
1. Progression: by longitudinal assessments of radiographic bone loss (RBL) or CAL.
For most patients progression rate must be confirmed using the most severe RBL
observed in relation to patient age (% bone loss / age ratio).
Bone loss assessment as a percentage of root length is inherently a rough estimate based
on the clinician’s interpretation of the most apical location of alveolar bone support,
location of the CEJ, and location of the root apex.
15. The example below (Figure) shows bone loss of approximately 60% or greater of root
length. In a 50-year-old patient, this would represent a greater than 1.0 bone loss / age
ratio, as shown in Table. A maximum bone loss ratio by age >1.0 will classify the patient as
Grade C based on progression rate.
16. 2. Risk Factors: The Grading table lists the two most well-documented risk factors for
periodontitis, namely smoking and diabetes mellitus.
Clinicians should consider a patient’s other systemic factors that may influence progression
of periodontitis and treatment, these may include obesity, chronic inflammatory diseases
such as rheumatoid arthritis, chronic depression, genetic factors, and other factors
from a comprehensive medical history.
3. Systemic Impact Risk: From evidence its clear that presence of certain chronic
inflammatory diseases influences the likelihood of a second chronic disease. Association of
periodontitis with other diseases such as CVS, Type II diabetes and APO is documented
but evidence that treatment of periodontitis will result in predictable benefits with
respect to any of those systemic conditions is rather limited.
4. Biomarkers: It is expected that additional evidence of clinical utility and further
advances with novel biomarkers may better inform objective assessments of Grade.
17.
18. AIM
To demonstrate the essential thought process to utilize the new periodontitis
classification
system in two challenging cases with gray zones that might hinder
straightforward case
definition with stage and grade.
19. Clinical Scenario 1
A 83-year-old male patient was referred (May/2019)
C/C => “I want to have healthy teeth again”.
D/H => His last periodontal maintenance was one month before visiting the clinic.
M/H => congestive heart failure since 2016 .
29. Clinical Scenario 2
73-yead-old male patient was referred on July of 2019.
C/C => “I don’t want to lose my teeth”.
D/H => Scaling and root planing which was done 15 years ago.
M/H => Controlled Hypertension, type 2 diabetes, basal cell carcinoma (removed in
2017)